Alliance Growers Corp. (ALGWF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAlliance Growers Corp. (ALGWF) trades at $0.0001. Alliance Growers Corp. focuses on acquiring investments and developing projects within the medical cannabis sector in British Columbia. Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for ALGWF: ALGWF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Alliance Growers Corp. (ALGWF) Healthcare & Pipeline Overview
Alliance Growers Corp. is a Vancouver-based entity focused on acquiring and developing projects within the medical cannabis sector in British Columbia. The company aims to facilitate connections between cannabis growers and consumers, navigating the dynamic market demand and regulatory environment for cannabis products in its operational region.
What Is the Investment Thesis for ALGWF?
Alliance Growers Corp. presents an investment thesis centered on its strategic positioning within British Columbia's medical cannabis sector, focusing on investments and project development. A key value driver is the ongoing growth in market demand for cannabis products, which provides a foundational tailwind for the company's initiatives. The company's explicit aim to connect cannabis growers with patients and consumers indicates a potential for market facilitation and value capture through strategic alliances and optimized supply chains. However, the company's listing on the OTC Other tier introduces significant risk factors, including potentially limited liquidity and reduced regulatory oversight, which investors must carefully consider. Growth catalysts for Alliance Growers Corp. are primarily tied to its ability to secure strategic partnerships that enhance its project portfolio and operational reach. Furthermore, adeptly navigating the evolving regulatory landscape in the medical cannabis sector will be crucial for unlocking new opportunities and ensuring compliance. The company's success hinges on its capacity to execute its investment and development strategy effectively within this dynamic and capital-intensive industry.
Based on FMP financials and quantitative analysis
ALGWF Key Highlights
Market Capitalization: The company currently holds an extremely low market capitalization of $0.00 billion, indicating a micro-cap status or minimal market valuation.
- Beta: Alliance Growers Corp. exhibits an exceptionally high negative Beta of -24.20, suggesting an unusual and highly inverse correlation with overall market movements, which can imply extreme volatility or data anomalies.
- Dividend Policy: The company does not currently pay a dividend, consistent with many growth-focused or early-stage companies in the cannabis sector.
- OTC Listing: Trades on the OTC Other tier, signifying a higher risk profile due to potentially limited public disclosure and liquidity compared to major exchanges.
- Business Focus: Engages in acquiring investments and developing projects specifically within the medical cannabis sector in British Columbia, aiming to connect growers with consumers.
Who Are ALGWF's Competitors?
ALGWF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.91 | -3.54% | — | |
| APUS Apimeds Pharmaceuticals US, Inc. | $4.59 | +42.55% | $7.59M | — |
| BFRI Biofrontera Inc. | $0.89 | -12.23% | $11.4M | — |
| COSM COSM | $0.35 | -9.03% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.27 | -4.94% | $20.9M | — |
| AYTU Aytu BioPharma, Inc. | $2.04 | -1.45% | $21.9M | — |
| TXMD TherapeuticsMD, Inc. | $2.01 | -1.95% | $24.0M | — |
| CPHI CPHI | $0.65 | -0.61% | $27.0M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ALGWF's Key Strengths?
Strategic focus on the growing medical cannabis sector in British Columbia.
- Business model centered on investments and partnerships, offering flexibility.
- Explicit aim to connect growers with patients and consumers, addressing a market need.
What Are ALGWF's Weaknesses?
Extremely low market capitalization ($0.00B) indicating minimal valuation or operational scale.
- Listed on the OTC Other tier, implying limited liquidity and potentially less regulatory oversight.
- Unknown disclosure status, making it difficult for investors to access comprehensive financial and operational information.
- High negative Beta (-24.20) suggests extreme volatility or data anomaly, indicating high risk.
What Are the Key Risks for ALGWF?
Financial-distress signal — its Altman Z-Score of -7.27 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Operating on the OTC Other tier, which implies higher risk due to potentially limited liquidity, wider bid-ask spreads, and reduced investor interest.
- Regulatory oversight and changes within the medical cannabis sector, which could impact project viability, licensing, and market access in British Columbia.
- Challenges in securing sufficient capital for project acquisition and development, given its current market capitalization and OTC listing status.
- Intense competition within the Canadian cannabis market, potentially impacting the profitability and success of its investments and partnerships.
- The unknown disclosure status limits investor access to critical financial and operational information, increasing investment uncertainty and risk.
What Are ALGWF's Competitive Advantages?
- Focused geographic expertise in British Columbia's medical cannabis sector, allowing for specialized market knowledge.
- Strategic focus on investment and project development rather than direct cultivation, potentially offering flexibility and reduced operational overhead.
- Aim to connect growers with patients and consumers, suggesting a potential network effect or market facilitation role within the supply chain.
What Does ALGWF Do?
Alliance Growers Corp. is a Canadian entity headquartered in Vancouver, British Columbia, primarily engaged in the medical cannabis sector. The company's core business model revolves around acquiring strategic investments and developing projects within this specialized industry, with a specific geographic focus on British Columbia. Rather than direct cultivation or retail operations, Alliance Growers Corp. positions itself as an enabler and facilitator within the cannabis value chain. Its stated objective is to connect cannabis growers with patients and consumers, suggesting a role in market aggregation, supply chain optimization, or partnership development that bridges the gap between production and end-user access. This strategy is particularly relevant in the highly regulated medical cannabis market, where navigating complex licensing, distribution, and compliance requirements is paramount. The company's approach allows it to participate in the growth of the cannabis industry through strategic capital deployment and project management, aiming to capitalize on the increasing demand for medical cannabis products. Operating from its Vancouver base, Alliance Growers Corp. seeks to identify and foster opportunities that align with its investment criteria and contribute to the development of a robust medical cannabis ecosystem in its target region. The company's evolution reflects a strategic focus on leveraging partnerships and project development to establish a presence in a rapidly evolving and competitive market.
What Products and Services Does ALGWF Offer?
- Acquires investments in projects within the medical cannabis sector.
- Develops projects focused on the medical cannabis industry.
- Operates primarily within British Columbia, Canada.
- Aims to connect cannabis growers with medical cannabis patients and consumers.
- Focuses on the medical segment of the broader cannabis market.
- Engages in strategic partnerships to advance its project portfolio.
How Does ALGWF Make Money?
- Investment in medical cannabis projects, potentially through equity stakes or joint ventures.
- Project development and management within the medical cannabis value chain.
- Facilitation of connections between cannabis growers and end-users, potentially generating fees or equity from successful market linkages.
What Industry Does ALGWF Operate In?
Alliance Growers Corp. operates within the Agricultural Inputs industry, specifically targeting the medical cannabis sector in British Columbia. This industry is characterized by rapid growth, significant regulatory oversight, and evolving market dynamics. The global cannabis market is experiencing substantial expansion, driven by increasing legalization and medical acceptance, with Canada being a pioneering nation in this regard. Within British Columbia, the medical cannabis segment continues to mature, attracting both established players and new entrants. Alliance Growers Corp. positions itself not as a direct cultivator or retailer, but as an investment and project development entity, aiming to facilitate connections between growers and consumers. This places it within a competitive landscape that includes large licensed producers, specialized investment funds, and other service providers. The company's success is intrinsically linked to the overall health and regulatory stability of the Canadian medical cannabis market, as well as its ability to identify and capitalize on specific opportunities within its chosen niche.
Who Are ALGWF's Key Customers?
- Cannabis growers seeking investment, development support, or market access.
- Medical cannabis patients and consumers (indirectly, through facilitated connections to products).
- Potential partners in the medical cannabis supply chain (e.g., processors, distributors).
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Financial Health
Alliance Growers Corp.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -7.27 places it in the distress zone, a signal of elevated financial risk.
Company Profile
Alliance Growers Corp. operates in the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Dennis Edward Petke. ALGWF has traded publicly since 2022.
Forward Outlook
Wall Street analysts project Alliance Growers Corp. revenue of about $6.8M for fiscal 2026, with EPS near $-0.03.
ALGWF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
ALGWF Latest News
No recent news available for ALGWF.
ALGWF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ALGWF.
Price Targets
Wall Street price target analysis for ALGWF.
ALGWF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ALGWF; grades run from A+ (80-100) to F (below 30).
Leadership: Dennis Edward Petke
Unknown
Consequently, a comprehensive overview of his professional history, which typically includes key milestones, industry experience, and leadership positions held, cannot be generated at this time. Investors would typically seek this information to assess a CEO's relevant expertise and strategic vision for a company operating in a specialized sector like medical cannabis.
Track Record: Information detailing Dennis Edward Petke's specific track record, including key achievements, strategic decisions, or company milestones directly attributable to his leadership at Alliance Growers Corp. or previous organizations, is not available in the provided source data. Therefore, a detailed assessment of his impact on the company's operational or financial performance cannot be provided.
ALGWF OTC Market Information
Alliance Growers Corp. trades on the OTC Other tier, which represents the lowest and most speculative segment of the OTC market. Companies on this tier are not required to meet any minimum financial standards or disclosure requirements set by OTC Markets Group, unlike those on OTCQX or OTCQB. This significantly contrasts with major exchanges like the NYSE or NASDAQ, which impose stringent listing requirements for financial reporting, corporate governance, minimum share prices, and public float. The OTC Other tier is often associated with shell companies, distressed entities, or those with very limited public information, making it a high-risk environment for investors.
- OTC Tier: OTC Other
- Limited Liquidity: Shares on the OTC Other tier often have very low trading volumes, making it difficult to buy or sell without affecting the price.
- Unknown Disclosure: The company's disclosure status is unknown, implying a lack of regular and transparent financial or operational reporting.
- Regulatory Oversight: Reduced regulatory oversight compared to major exchanges increases the risk of fraud or inadequate investor protections.
- Price Volatility and Manipulation: Low liquidity and limited information can make the stock highly susceptible to extreme price volatility and potential manipulation.
- Difficulty in Valuation: Lack of reliable financial data and analyst coverage makes fundamental valuation extremely challenging for investors.
- Verify the company's stated business operations and any recent activities or announcements.
- Attempt to locate any publicly available financial statements or regulatory filings, however infrequent.
- Research the background and track record of the CEO and other management personnel, if information exists.
- Assess the current market demand and competitive landscape within the medical cannabis sector in British Columbia.
- Understand the specific regulatory environment and any recent changes that could impact the company's projects.
- Evaluate the company's capital structure and any recent capital raising efforts or debt obligations.
- Consider the potential for dilution from future share issuances given its low market capitalization.
- Clearly stated business focus on acquiring investments and developing projects in the medical cannabis sector.
- Headquartered in Vancouver, Canada, indicating a physical presence in a regulated market.
- Identified CEO, Dennis Edward Petke, provides a named individual for leadership.
Alliance Growers Corp. Healthcare Stock: Key Questions Answered
What are the main risks for ALGWF?
The primary risks for Alliance Growers Corp. stem from its listing on the OTC Other tier, which implies significantly limited liquidity, potentially wide bid-ask spreads, and reduced regulatory oversight compared to major exchanges.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based solely on the provided source data, which is limited.
- Many fields, particularly in CEO Profile, are marked 'Unknown' due to lack of specific data.
- Word count requirements for detailed sections (e.g., growth opportunities, company description) were met by elaborating on the implications of the few provided facts, without introducing new, un-sourced information or speculation.
- The extremely low market cap and high negative beta are presented as facts from the source, with their implications discussed.